Combination Drugs
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2026 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Maker:
Gilead Sciences
What it does:
Helps prevent replication of HIV
Traditional dosage:
One tablet (300 mg atazanavir and 150 mg cobicistat) once daily with food, in combination with other antiretroviral drugs. Atazanavir (Reyataz) is a protease inhibitor and cobicistat (Tybost) a boosting agent.
Drug interactions, precautions, & recommendations:
Do not take with protease inhibitors, roxatral, Propulsid, Propulsid Quicksolv, Mitigare, Colcrys, Multaq, D.H.E. 45, Embolex, Migranal, Cafergot, Migergot, Ergomar, Ergostat, Medihaler, Wigraine, Wigrettes, Ergotrate, Methergine, Crixivan, Camptosar, Advicor, Altoprev, Mevacor, Latuda, Versed, Viramune, Viramune XR, Orap, Ranexa, Rimactane, Rifadin, Rifater, Rifamate, Revatio (when used for lung problems), Zocor, Vytorin, Simcor, Halcion, or St John’s Wort. Use with caution if you have heart, liver, or kidney problems; diabetes; hemophilia; or if you are pregnant, plan to become pregnant, or are using hormonal birth control. Do not breastfeed.
Side effects:
Most serious: heart rhythm changes, kidney or gallbladder problems, worsening liver problems, severe skin rash, diabetes or worsening diabetes, increased bleeding with hemophilia, changes in body fat or immune system
Other: nausea, yellowing of the skin or whites of the eyes
From our Sponsors
Most Popular
The road to U=U: How science has been liberating HIV+ people for a decade
July 01 2026 12:05 PM
Newly diagnosed with HIV? Advocates share their best advice for seeking treatment
April 29 2026 3:32 PM
How to find an HIV-competent healthcare provider, according to advocates
May 19 2026 4:55 PM
Plus: Featured Video
Latest Stories
A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light
August 31 2026 2:31 PM
Why affirming faith communities belong in the fight to end HIV
August 30 2026 8:00 AM
Navigating a new HIV diagnosis? Advocates say community is key
August 25 2026 3:33 PM
Gay Wine Weekend toasts 15 years of raising funds for HIV
August 25 2026 11:00 AM
A new HIV diagnosis doesn't have to be nerve-wracking. Advocates share their advice
July 30 2026 12:01 PM
Zero HIV Stigma Day: The epidemic we still choose to ignore
July 21 2026 7:00 AM
National HIV Prevention Day: Awareness is my superpower
July 17 2026 8:00 AM
Federal court clarifies that people with HIV can join the military again
June 03 2026 5:36 PM
Can a single infusion of immune cells suppress HIV for years?
May 11 2026 11:39 AM
National HIV advocacy group's CEO rejects claims of crisis
April 21 2026 5:14 PM
Beyond awareness: How youth leadership is reshaping the HIV response
April 10 2026 9:12 AM
Saving public health? AIDS United's new CEO has a plan
March 23 2026 9:48 AM
Struggling with daily HIV meds? Monthly shots may be the answer
March 20 2026 7:12 AM
Trending stories
Recommended Stories for You


































































